Cancer Biopsy Market Size, Forecast & Analysis by 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Cancer Biopsy Market Size Analysis

Global Cancer Biopsy Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Kits and Consumables
  1. By Value
4. Services
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tissue Biopsies
  1. By Value
3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
  1. By Value
4. Liquid Biopsies
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast Cancer
  1. By Value
3. Colorectal Cancer
  1. By Value
4. Cervical Cancers
  1. By Value
5. Lung Cancers
  1. By Value
6. Prostate Cancers
  1. By Value
7. Skin Cancers
  1. By Value
8. Blood Cancers
  1. By Value
9. Kidney Cancers
  1. By Value
10. Liver Cancers
  1. By Value
11. Pancreatic Cancers
  1. By Value
12. Ovarian Cancers
  1. By Value
13. Others
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Kits and Consumables
  1. By Value
4. Services
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tissue Biopsies
  1. By Value
3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
  1. By Value
4. Liquid Biopsies
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast Cancer
  1. By Value
3. Colorectal Cancer
  1. By Value
4. Cervical Cancers
  1. By Value
5. Lung Cancers
  1. By Value
6. Prostate Cancers
  1. By Value
7. Skin Cancers
  1. By Value
8. Blood Cancers
  1. By Value
9. Kidney Cancers
  1. By Value
10. Liver Cancers
  1. By Value
11. Pancreatic Cancers
  1. By Value
12. Ovarian Cancers
  1. By Value
13. Others
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Kits and Consumables
    1. By Value
  4. Services
    1. By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Tissue Biopsies
    1. By Value
  3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
    1. By Value
  4. Liquid Biopsies
    1. By Value
  5. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast Cancer
    1. By Value
  3. Colorectal Cancer
    1. By Value
  4. Cervical Cancers
    1. By Value
  5. Lung Cancers
    1. By Value
  6. Prostate Cancers
    1. By Value
  7. Skin Cancers
    1. By Value
  8. Blood Cancers
    1. By Value
  9. Kidney Cancers
    1. By Value
  10. Liver Cancers
    1. By Value
  11. Pancreatic Cancers
    1. By Value
  12. Ovarian Cancers
    1. By Value
  13. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Kits and Consumables
  1. By Value
4. Services
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tissue Biopsies
  1. By Value
3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
  1. By Value
4. Liquid Biopsies
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast Cancer
  1. By Value
3. Colorectal Cancer
  1. By Value
4. Cervical Cancers
  1. By Value
5. Lung Cancers
  1. By Value
6. Prostate Cancers
  1. By Value
7. Skin Cancers
  1. By Value
8. Blood Cancers
  1. By Value
9. Kidney Cancers
  1. By Value
10. Liver Cancers
  1. By Value
11. Pancreatic Cancers
  1. By Value
12. Ovarian Cancers
  1. By Value
13. Others
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Kits and Consumables
    1. By Value
  4. Services
    1. By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Tissue Biopsies
    1. By Value
  3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
    1. By Value
  4. Liquid Biopsies
    1. By Value
  5. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast Cancer
    1. By Value
  3. Colorectal Cancer
    1. By Value
  4. Cervical Cancers
    1. By Value
  5. Lung Cancers
    1. By Value
  6. Prostate Cancers
    1. By Value
  7. Skin Cancers
    1. By Value
  8. Blood Cancers
    1. By Value
  9. Kidney Cancers
    1. By Value
  10. Liver Cancers
    1. By Value
  11. Pancreatic Cancers
    1. By Value
  12. Ovarian Cancers
    1. By Value
  13. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Kits and Consumables
  1. By Value
4. Services
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tissue Biopsies
  1. By Value
3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
  1. By Value
4. Liquid Biopsies
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast Cancer
  1. By Value
3. Colorectal Cancer
  1. By Value
4. Cervical Cancers
  1. By Value
5. Lung Cancers
  1. By Value
6. Prostate Cancers
  1. By Value
7. Skin Cancers
  1. By Value
8. Blood Cancers
  1. By Value
9. Kidney Cancers
  1. By Value
10. Liver Cancers
  1. By Value
11. Pancreatic Cancers
  1. By Value
12. Ovarian Cancers
  1. By Value
13. Others
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Kits and Consumables
    1. By Value
  4. Services
    1. By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Tissue Biopsies
    1. By Value
  3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
    1. By Value
  4. Liquid Biopsies
    1. By Value
  5. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast Cancer
    1. By Value
  3. Colorectal Cancer
    1. By Value
  4. Cervical Cancers
    1. By Value
  5. Lung Cancers
    1. By Value
  6. Prostate Cancers
    1. By Value
  7. Skin Cancers
    1. By Value
  8. Blood Cancers
    1. By Value
  9. Kidney Cancers
    1. By Value
  10. Liver Cancers
    1. By Value
  11. Pancreatic Cancers
    1. By Value
  12. Ovarian Cancers
    1. By Value
  13. Others
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Kits and Consumables
  1. By Value
4. Services
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tissue Biopsies
  1. By Value
3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
  1. By Value
4. Liquid Biopsies
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast Cancer
  1. By Value
3. Colorectal Cancer
  1. By Value
4. Cervical Cancers
  1. By Value
5. Lung Cancers
  1. By Value
6. Prostate Cancers
  1. By Value
7. Skin Cancers
  1. By Value
8. Blood Cancers
  1. By Value
9. Kidney Cancers
  1. By Value
10. Liver Cancers
  1. By Value
11. Pancreatic Cancers
  1. By Value
12. Ovarian Cancers
  1. By Value
13. Others
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Kits and Consumables
    1. By Value
  4. Services
    1. By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Tissue Biopsies
    1. By Value
  3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
    1. By Value
  4. Liquid Biopsies
    1. By Value
  5. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast Cancer
    1. By Value
  3. Colorectal Cancer
    1. By Value
  4. Cervical Cancers
    1. By Value
  5. Lung Cancers
    1. By Value
  6. Prostate Cancers
    1. By Value
  7. Skin Cancers
    1. By Value
  8. Blood Cancers
    1. By Value
  9. Kidney Cancers
    1. By Value
  10. Liver Cancers
    1. By Value
  11. Pancreatic Cancers
    1. By Value
  12. Ovarian Cancers
    1. By Value
  13. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Kits and Consumables
  1. By Value
4. Services
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Tissue Biopsies
  1. By Value
3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
  1. By Value
4. Liquid Biopsies
  1. By Value
5. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Breast Cancer
  1. By Value
3. Colorectal Cancer
  1. By Value
4. Cervical Cancers
  1. By Value
5. Lung Cancers
  1. By Value
6. Prostate Cancers
  1. By Value
7. Skin Cancers
  1. By Value
8. Blood Cancers
  1. By Value
9. Kidney Cancers
  1. By Value
10. Liver Cancers
  1. By Value
11. Pancreatic Cancers
  1. By Value
12. Ovarian Cancers
  1. By Value
13. Others
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Kits and Consumables
    1. By Value
  4. Services
    1. By Value
2. By Type
  1. Introduction
    1. Type By Value
  2. Tissue Biopsies
    1. By Value
  3. Needle Biopsies {Fine Needle Aspiration [FNA] and Core Needle Biopsy [CNB]} and Surgical Biopsies)
    1. By Value
  4. Liquid Biopsies
    1. By Value
  5. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Breast Cancer
    1. By Value
  3. Colorectal Cancer
    1. By Value
  4. Cervical Cancers
    1. By Value
  5. Lung Cancers
    1. By Value
  6. Prostate Cancers
    1. By Value
  7. Skin Cancers
    1. By Value
  8. Blood Cancers
    1. By Value
  9. Kidney Cancers
    1. By Value
  10. Liver Cancers
    1. By Value
  11. Pancreatic Cancers
    1. By Value
  12. Ovarian Cancers
    1. By Value
  13. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Cancer Biopsy Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Qiagen N.V.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Illumina, Inc.
ANGLE Plc
Myriad Genetics
Hologic, Inc.
Danaher
F. Hoffmann-La Roche Ltd.
Biocept, Inc.
Lucence Diagnostics Pte. Ltd.
GRAIL, Inc.
Exact Sciences Corporation
Thermo Fisher Scientific, Inc.
Guardant Health
Freenome Holdings, Inc.
Biodesix (Integrated Diagnostics)
Oncimmune
Epigenomics AG.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment